Skip to main content
. Author manuscript; available in PMC: 2010 Jun 25.
Published in final edited form as: J Cell Biochem. 2009 Nov 1;108(4):832–838. doi: 10.1002/jcb.22311

Fig. 5.

Fig. 5

Effect of Akt1 AO on the human glioblastoma U251 tumor xenograft. Nude micebearing U251 tumorsweretreated bytail veil injections every other day for 3 weeks with either saline as vehicle control (○) or Akt1 AO at dose of 30 mg/kg (●) per injection. After Akt1 AO treatment for 3 weeks, the mice were observed for up to 30 more days to detect possible tumor regrowth. Data shown are average tumor weight ±SEM (n = 6–8 per group).